Fig. 1 · Structure
Documents & Downloads
Anticancer agent 129
Anti-Cancer Agent
Anticancer agent 129, a quinoline derivative, exhibits potent anti-cancer activity by targeting key cellular pathways involved in tumor growth and proliferation. This compound has demonstrated efficacy in preclinical studies, making it a valuable tool for cancer research and therapeutic development. Its application spans various cancer types, providing insights into mechanisms underlying tumor biology and potential treatment strategies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 135882-37-0 |
| Applications | Anti-Cancer Agent |
| Formula | C18H17N3 |
| Molecular Weight | 275.35 |
| SMILES | NC1=C2C(N(CC3=CC=CC=C3)CC2)=NC4=CC=CC=C14 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.